Omega Pharma NV in Consumer Health (Belgium)

August 2013 | 4 pages | ID: OE5D4FFD7A5EN
Euromonitor International Ltd

Abstracts

In addition to its international expansion, Omega Pharma should continue to develop a product strategy of focusing its resources on dermatological, respiratory and antiparasitic products, as well as pregnancy tests and dietary supplements. The company is expected to also focus on its 20 local brands, selected on the basis of potential market growth and strategic opportunities. Of these 20 brands, some are more particularly known in Belgium, such as Bodysol/Galenco, Davitamon, Predictor,...

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Omega Pharma Belgium NV: Key Facts
Summary 2 Omega Pharma Belgium NV: Operational Indicators
Company Background
Production
Summary 3 Omega Pharma NV: Production Statistics 2012
Competitive Positioning
Summary 4 Omega Pharma NV: Competitive Position 2012